kff employer health benefits survey 2025 glp-1 coverage Large employers embrace GLP-1s The Ozempic, Semaglutide, and GLP-1

Diabetes Complic

Precision during the first four weeks matters because under-dosing delays your body adjustment to the medication, while over-dosing triggers unnecessary nausea that can shake your confidence in the treatment

But you deserve to understand exactly what you are getting and make an informed choice rather than assuming compounded products are identical in every way to brand-name medications

That is consistent with Novos own low single digit negative guidance for 2026 global sales growth

IHence, ultimately only a minority navigate access

Quick Answer: GLP-1 receptor agonist medications do not appear on standard blood tests, drug screenings, or employment panels